Health

#SFHS2608303VNotice on Health Insurance Participation Rates for Pharmaceutical Specialties

🇫🇷France··Other·Low Impact·View source ↗

AI-generated summary for informational purposes only. Not legal advice. See the original source for the authoritative text.

🇬🇧 English

This notice sets the insurance participation rates for certain pharmaceutical specialties in France. The medications affected are specific dosages of Micafungin, which have a set participation rate of 35%. This affects how much insured individuals will pay for these medications.

AI-generated summary. May contain errors. Refer to official sources for legal decisions.

Key Changes

  • Sets a 35% participation rate for Micafungin 50mg and 100mg
  • Impacts insured individuals' out-of-pocket costs for these dosages

Obligations

What this law requires

high

Apply a 35% patient participation rate for MICAFUNGINE ACC 50MG PERF FL (UCD code 34008 900 384 4 7)

Health insurance funds (caisses d'assurance maladie), pharmacies, healthcare providers
operational
high

Apply a 35% patient participation rate for MICAFUNGINE ACC 100MG PERF FL (UCD code 34008 900 384 3 0)

Health insurance funds (caisses d'assurance maladie), pharmacies, healthcare providers
operational
high

Implement the participation rate decision issued by the Director General of the Union nationale des caisses d'assurance maladie effective from March 10, 2026

All health insurance funds and participating pharmacies in France
operational

Affected Parties

Patients using MicafunginHealth insurance providers

Tags

pharmaceuticals,health insurance,France